文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

早产儿视网膜病变治疗的国际差异与趋势

International variations and trends in the treatment for retinopathy of prematurity.
PubMed 文献 · Br J Ophthalmol · 2017-03-07

该回顾性队列研究比较了参加iNeo网络的高收入国家中极早产儿视网膜病变(ROP)的发生率和治疗率。在48 087名婴儿中,任何ROP的发生率在瑞士和日本分别为25.2%和91.0%,总体治疗率为24.9%,各国间差异显著,且研究期间ROP治疗总体呈下降趋势。

要点

  • 在受检婴儿中,任何ROP的发生率从瑞士的25.2%到日本的91.0%不等。
  • 总体ROP治疗率为24.9%,各国间从4.3%到30.4%不等。
  • 研究期间ROP治疗总体呈下降趋势,但差异原因尚不明确。

核心结论

  • iNeo成员间任何ROP发生率和ROP治疗率存在显著差异,研究期间ROP治疗总体呈下降趋势。
  • 这些差异是否反映护理实践、诊断和/或治疗阈值的不同尚不清楚。

研究设计与样本

  • 回顾性队列研究,纳入2007年至2013年间澳大利亚/新西兰、加拿大、芬兰、以色列、日本、西班牙、瑞典、瑞士、意大利托斯卡纳和英国新生儿病房收治的出生体重<1500 g、胎龄240至276周的极早产儿。
  • 采用泊松分析和多因素logistic回归分析(校正混杂因素后)进行国家间两两比较,并使用logistic回归和标准化比值比较死亡或ROP治疗的复合结局。

主要发现

  • 共纳入48 087名婴儿,81.8%存活至矫正胎龄32周,95%的存活者接受了ROP筛查。
  • 在受检婴儿中,任何ROP的发生率从瑞士的25.2%到日本的91.0%不等。
  • 总体治疗率为24.9%,各国间从4.3%到30.4%不等。
  • 校正后风险比显示,瑞士在所有两两比较中ROP治疗风险较低,而日本显示显著较高的比值。
  • 国家间复合结局比较显示相似但较不明显的差异。

局限性

  • 这些差异是否反映护理实践、诊断和/或治疗阈值的不同尚不清楚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the rates of retinopathy of prematurity (ROP) and treatment of ROP by laser or intravitreal anti-vascular endothelial growth factor among preterm neonates from high-income countries participating in the International Network for Evaluating Outcomes (iNeo) of neonates. METHODS: A retrospective cohort study was conducted on extremely preterm infants weighing <1500 g at 240 to 276 weeks' gestation who were admitted to neonatal units in Australia/New Zealand, Canada, Finland, Israel, Japan, Spain, Sweden, Switzerland, Tuscany (Italy) and the UK between 2007 and 2013. Pairwise comparisons of ROP treatment in survivors between countries were evaluated by Poisson and multivariable logistic regression analyses after adjustment for confounders. A composite outcome of death or ROP treatment was compared between countries using logistic regression and standardised ratios. RESULTS: Of 48 087 infants included in the analysis, 81.8% survived to 32 weeks postmenstrual age, and 95% of survivors were screened for ROP. Rates of any ROP ranged from 25.2% to 91.0% in Switzerland and Japan, respectively, among those examined. The overall rate of those receiving treatment was 24.9%, which varied from 4.3% to 30.4%. Adjusted risk ratios for ROP treatment were lower for Switzerland in all pairwise comparisons, whereas Japan displayed significantly higher ratios. Comparisons of the composite outcome between countries revealed similar, but less marked differences. CONCLUSIONS: Rates of any ROP and ROP treatment varied significantly between iNeo members, while an overall decline in ROP treatment was observed during the study period. It is unclear whether these variations represent differences in care practices, diagnosis and/or treatment thresholds.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Darlow BA, Lui K, Kusuda S, et al. International variations and trends in the treatment for retinopathy of prematurity. Br J Ophthalmol. 2017. PMID: 28270489. doi:10.1136/bjophthalmol-2016-310041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。